Human papillomavirus (HPV) vaccination and the development of public policies

Journal of Epidemiology and Community Health

Volumn 62, Issue 7, 2008, Pages 570-571

  Lippman, Abby ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; WART VIRUS VACCINE;

CANCER PREVENTION; EDITORIAL; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; CANADA; CHILD; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PUBLIC POLICY; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

HUMAN PAPILLOMAVIRUS;

EID: 46949098050     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2008.074740     Document Type: Editorial

References (12)

1. Angelmar R, Angelmar S, Kane L. Building strong condition brands. J Med Marketing 2007;7:341-51.
2. Australian Government, Department of Health and Ageing: Fact Sheet: Government funding of Gardasil, Updated 28 November 2006. http://www.health.gov.au/internet/main/publishing.nsf/Content/ 4754B33584405E06CA2572220008CFA8/$File/Gardasilfunding-factsheet.pdf (accessed 15 Apr 2008).
3. CWHN. HPV, Vaccines, and Gender: Policy Considerations. Posted 25 June 2007 http://www.cwhn.ca/PDF/CWHN_HPVjuly30.pdf (accessed 1 Feb 2008).
4. Lippman A, Melnychuk R, Shimmin C, et al. Human papillomavirus, vaccines and women's health. Can Med Assoc J 2007;177:484-7.
5. Lippman A, Boscoe M, Scurfield C. Debate: Do you approve of spending $300 million on HPV vaccination? No. Can Fam Phys 2008;54:175-7.
6. Declaration. Razones para una moratoria en la aplicación de la vacuna del virus del papiloma humano en España. 2007. http://www.caps.pangea.org/declaracion/ (accessed 6 Apr 2008).
7. Gérvas J. La incierta prevencion del cancer de cuello de utero con la vacuna contra el Virus del Papiloma Humano. Rev Port Clin Geral 2007;23:547-55.
8. Decker K, Demers AA, Chateau D, et al. Cervical cancer in Manitoba: evaluating Pap test utilization, cancer risk, and opportunity to be screened. Open Med (in press).
9. Reisinger KS, Block SL, Lazcano-Ponce E, et al. Safety and persistent immunogenicity of quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J 2007;26:201-9.
10. Rambout L, Hopkins L, Hutton B, et al. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. Can Med Assoc J 2007;177:469-79.
11. Krieger N. Proximal, distal, and the politics of causation: What's level got to do with it? Am J Publ Health 2008;98:221-30.
12. Rose N. Molecular biopolitics, somatic ethics and the spirit of biocapital. Soc Theory Health 2007;15:3-29.